BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 32956572)

  • 1. Methods for Automated Single Cell Isolation and Sub-Cloning of Human Pluripotent Stem Cells.
    Vallone VF; Telugu NS; Fischer I; Miller D; Schommer S; Diecke S; Stachelscheid H
    Curr Protoc Stem Cell Biol; 2020 Dec; 55(1):e123. PubMed ID: 32956572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving single-cell cloning workflow for gene editing in human pluripotent stem cells.
    Chen YH; Pruett-Miller SM
    Stem Cell Res; 2018 Aug; 31():186-192. PubMed ID: 30099335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Semi-automated optimized method to isolate CRISPR/Cas9 edited human pluripotent stem cell clones.
    Frank E; Cailleret M; Nelep C; Fragner P; Polentes J; Herardot E; El Kassar L; Giraud-Triboult K; Monville C; Ben M'Barek K
    Stem Cell Res Ther; 2023 Apr; 14(1):110. PubMed ID: 37106426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient and scalable culture of single dissociated human pluripotent stem cells using recombinant E8 fragments of human laminin isoforms.
    Miyazaki T; Kawase E
    Curr Protoc Stem Cell Biol; 2015 Feb; 32():1C.18.1-1C.18.8. PubMed ID: 25640816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical Reversion of Conventional Human Pluripotent Stem Cells to a Naïve-like State with Improved Multilineage Differentiation Potency.
    Park TS; Zimmerlin L; Evans-Moses R; Zambidis ET
    J Vis Exp; 2018 Jun; (136):. PubMed ID: 29939183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generating CRISPR-Cas9-Mediated Null Mutations and Screening Targeting Efficiency in Human Pluripotent Stem Cells.
    Bower OJ; McCarthy A; Lea RA; Alanis-Lobato G; Zohren J; Gerri C; Turner JMA; Niakan KK
    Curr Protoc; 2021 Aug; 1(8):e232. PubMed ID: 34432381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing Cell Competition in Human Pluripotent Stem Cell (hPSC) Cultures.
    Price CJ; Barbaric I
    Curr Protoc; 2022 May; 2(5):e435. PubMed ID: 35621694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Robust protocol for feeder-free adaptation of cryopreserved human pluripotent stem cells.
    Aalders J; Van den Vreken N; Popovic M; Mishra S; Heindryckx B; van Hengel J
    In Vitro Cell Dev Biol Anim; 2019 Dec; 55(10):777-783. PubMed ID: 31664691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient and safe single-cell cloning of human pluripotent stem cells using the CEPT cocktail.
    Tristan CA; Hong H; Jethmalani Y; Chen Y; Weber C; Chu PH; Ryu S; Jovanovic VM; Hur I; Voss TC; Simeonov A; Singeç I
    Nat Protoc; 2023 Jan; 18(1):58-80. PubMed ID: 36261632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Efficient Protocol for Single-Cell Cloning Human Pluripotent Stem Cells.
    Singh AM
    Front Cell Dev Biol; 2019; 7():11. PubMed ID: 30766873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimized and Scalable Precoating-Free Reprogramming of Human Peripheral Blood Mononuclear Cells into iPSCs.
    Fiacco E; Landi S; Zasso J; Ambrosini C; Faga G
    Curr Protoc; 2024 Jan; 4(1):e979. PubMed ID: 38265186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bio-inspired oligovitronectin-grafted surface for enhanced self-renewal and long-term maintenance of human pluripotent stem cells under feeder-free conditions.
    Park HJ; Yang K; Kim MJ; Jang J; Lee M; Kim DW; Lee H; Cho SW
    Biomaterials; 2015 May; 50():127-39. PubMed ID: 25736503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of Wnt and Activin/Nodal supports efficient derivation, cloning and suspension expansion of human pluripotent stem cells.
    Ai Z; Niu B; Duan K; Si C; Wang S; Xiang L; Zhu X; Zhu Q; Feng C; Yin Y; Zhao S; Kong R; Ji W; Li T
    Biomaterials; 2020 Aug; 249():120015. PubMed ID: 32311594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and expansion of human pluripotent stem cell-derived hepatic progenitor cells by growth factor defined serum-free culture conditions.
    Fukuda T; Takayama K; Hirata M; Liu YJ; Yanagihara K; Suga M; Mizuguchi H; Furue MK
    Exp Cell Res; 2017 Mar; 352(2):333-345. PubMed ID: 28215634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the effects of cell seeding density on the differentiation of human pluripotent stem cells to brain microvascular endothelial cells.
    Wilson HK; Canfield SG; Hjortness MK; Palecek SP; Shusta EV
    Fluids Barriers CNS; 2015 May; 12():13. PubMed ID: 25994964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled Growth and the Maintenance of Human Pluripotent Stem Cells by Cultivation with Defined Medium on Extracellular Matrix-Coated Micropatterned Dishes.
    Takenaka C; Miyajima H; Yoda Y; Imazato H; Yamamoto T; Gomi S; Ohshima Y; Kagawa K; Sasaki T; Kawamata S
    PLoS One; 2015; 10(6):e0129855. PubMed ID: 26115194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developing CRISPR/Cas9-Mediated Fluorescent Reporter Human Pluripotent Stem-Cell Lines for High-Content Screening.
    Vojnits K; Nakanishi M; Porras D; Kim Y; Feng Z; Golubeva D; Bhatia M
    Molecules; 2022 Apr; 27(8):. PubMed ID: 35458632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clump-passaging-based efficient 3D culture of human pluripotent stem cells under chemically defined conditions.
    Lee MO; Jeon H; Son MY; Lee SC; Cho YS
    Biochem Biophys Res Commun; 2017 Nov; 493(1):723-730. PubMed ID: 28859981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probing flecainide block of I
    Geng L; Kong CW; Wong AOT; Shum AM; Chow MZY; Che H; Zhang C; Yau KL; Chan CW; Keung W; Li RA
    Toxicol Lett; 2018 Sep; 294():61-72. PubMed ID: 29758359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative cultures for human pluripotent stem cell production, maintenance, and genetic analysis.
    Chen KG; Hamilton RS; Robey PG; Mallon BS
    J Vis Exp; 2014 Jul; (89):. PubMed ID: 25077932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.